HARVARD BIOSCIENCE, INC. Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities
HARVARD BIOSCIENCE, INC. (HBIO) reported Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities of -$1.60 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialLiabilities · last filed 2019-03-18
- HARVARD BIOSCIENCE, INC. business combination, provisional information, initial accounting incomplete, adjustment, financial liabilities for the quarter ending 2018-06-30 was -$1.60M.
- HARVARD BIOSCIENCE, INC. business combination, provisional information, initial accounting incomplete, adjustment, financial liabilities for fiscal 2018 was -$1.60M.
| Period end | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities 3 month | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financial Liabilities 12 month |
|---|---|---|
| 2018-12-31 | -$1.60M 10-K · filed 2019-03-18 | |
| 2018-06-30 | -$1.60M 10-Q · filed 2018-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |